← AI Health Hub

Emergency 2 min read

AI Identifies Fatty Liver Disease Using Chest X-Rays

AI detects fatty liver disease using chest X-rays, offering a cost-effective and accessible diagnostic method. 🩻💡

Yusuf Yesil, MD, MIS

AI Identifies Fatty Liver Disease Using Chest X-Rays

Overview

Fatty liver disease, characterized by fat accumulation in the liver, affects approximately one in four individuals globally. Early detection is vital to prevent severe complications such as cirrhosis and liver cancer.

Current Diagnostic Methods

Traditional diagnostic methods for fatty liver disease include:

  • Ultrasounds
  • CT scans
  • MRIs

These methods require expensive equipment and specialized facilities. In contrast, chest X-rays are more commonly performed, cost-effective, and involve lower radiation exposure. Although primarily used for assessing lung and heart conditions, chest X-rays can also reveal signs of fatty liver disease.

Research Development

A research team from Osaka Metropolitan University, led by Associate Professors Sawako Uchida-Kobayashi and Daiju Ueda, has developed an AI model capable of detecting fatty liver disease from chest X-ray images. This study utilized:

  • 6,599 chest X-ray images
  • Data from 4,414 patients

The AI model was trained using controlled attenuation parameter (CAP) scores and demonstrated high accuracy, with an area under the receiver operating characteristic curve (AUC) between 0.82 and 0.83.

Future Implications

Professor Uchida-Kobayashi expressed optimism about the potential of this diagnostic method, stating, “The development of diagnostic methods using easily obtainable and inexpensive chest X-rays has the potential to improve fatty liver detection. We hope it can be put into practical use in the future.”

Reference

Ueda D, Uchida-Kobayashi S, Yamamoto A, Walston SL, Motoyama H, Fujii H, Watanabe T, Miki Y, Kawada N. Performance of a Chest Radiograph-based Deep Learning Model for Detecting Hepatic Steatosis. Radiol Cardiothorac Imaging. 2025 Jun;7(3):e240402. doi: 10.1148/ryct.240402

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment.

Yusuf Yesil, MD, MIS
Yusuf Yesil, MD, MIS

Founder & Medical Doctor at Yesil Science. Clinical Biochemistry Specialist and Health AI researcher focused on clinical decision support, diagnostic AI, and biomedical machine learning.

Follow AI Health Hub